Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.56 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.55 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.52 |
| ▸ | PARP1 | P09874 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.52 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.52 |
| ▸ | NNMT | P40261 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HPGDS | O60760 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.45 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3133220 | 1.00 | APP (0.56) | APPSIRT6PARP10PARP1CA1 | |
| Hydrochloric Acid SCHEMBL31539646 | 0.98 | APP (0.55) | APPSIRT6PARP10PARP1CA1 | |
| SCHEMBL18496090 | 0.87 | NNMT (0.49) | APPSIRT6PARP10PARP1CA1 | |
| SCHEMBL287134 | 0.82 | P4HTM (0.60) | CA1CA2KMT2ADRD3P4HTM | |
| SCHEMBL2187078 | 0.82 | DRD3 (0.47) | APPCA1CA2DRD3P4HTM | |
| SCHEMBL10157712 | 0.82 | PRSS1 (0.53) | APPSIRT6PARP10PARP1CA1 | |
| SCHEMBL31424227 | 0.82 | PRSS1 (0.53) | APPSIRT6PARP10PARP1CA1 | |
| SCHEMBL6302880 | 0.81 | PARP10 (0.58) | APPSIRT6PARP10KMT2AP4HTM | |
| SCHEMBL29889518 | 0.81 | CHEK2 (0.48) | APPSIRT6PARP10NNMTKMT2A | |
| SCHEMBL16011699 | 0.81 | P4HTM (0.59) | CA1CA2KMT2ADRD3P4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569647-A | Buried material compound and application thereof in perovskite battery | 厦门紫金新能源新材料科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-122055155-A | Percutaneous absorption composition | 美德阿利克斯株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-122055155-A | Percutaneous absorption composition | 美德阿利克斯株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-119569647-A | Buried material compound and application thereof in perovskite battery | 厦门紫金新能源新材料科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024206939-A2 | SARS-COV-2 ENTRY INHIBITORS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-10-03 | — | — | WO | disclosed |
| CN-116547282-A | Heterocyclic compounds and their use for the treatment of helminth infections and diseases | 新基公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-115210227-A | Heterobifunctional molecules as TEAD inhibitors | 基因泰克公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220202815-A1 | TREATMENT OF CANCER | MINGSIGHT PHARMACEUTICALS, INC. | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202815-A1 | TREATMENT OF CANCER | PRKACB, PRKDC, PRKCH | APP 4807/4885SIRT6 2981/4885PARP10 1896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.